Exponent (EXPO) Competitors $79.90 -1.08 (-1.33%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$79.92 +0.02 (+0.02%) As of 08:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EXPO vs. FCN, DNB, CBZ, HURN, VSEC, ICFI, CRAI, ACTG, MG, and FCShould you be buying Exponent stock or one of its competitors? The main competitors of Exponent include FTI Consulting (FCN), Dun & Bradstreet (DNB), CBIZ (CBZ), Huron Consulting Group (HURN), VSE (VSEC), ICF International (ICFI), CRA International (CRAI), Acacia Research (ACTG), Mistras Group (MG), and Franklin Covey (FC). These companies are all part of the "research & consulting services" industry. Exponent vs. FTI Consulting Dun & Bradstreet CBIZ Huron Consulting Group VSE ICF International CRA International Acacia Research Mistras Group Franklin Covey Exponent (NASDAQ:EXPO) and FTI Consulting (NYSE:FCN) are both mid-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, community ranking, media sentiment, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation. Does the media prefer EXPO or FCN? In the previous week, FTI Consulting had 3 more articles in the media than Exponent. MarketBeat recorded 13 mentions for FTI Consulting and 10 mentions for Exponent. Exponent's average media sentiment score of 1.44 beat FTI Consulting's score of 1.29 indicating that Exponent is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Exponent 8 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive FTI Consulting 11 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, EXPO or FCN? FTI Consulting has higher revenue and earnings than Exponent. FTI Consulting is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioExponent$558.51M7.27$109M$2.1237.69FTI Consulting$3.70B1.60$274.89M$7.8021.16 Do analysts prefer EXPO or FCN? Exponent presently has a consensus target price of $120.00, indicating a potential upside of 50.19%. FTI Consulting has a consensus target price of $175.50, indicating a potential upside of 6.31%. Given Exponent's stronger consensus rating and higher possible upside, research analysts clearly believe Exponent is more favorable than FTI Consulting.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Exponent 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00FTI Consulting 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Is EXPO or FCN more profitable? Exponent has a net margin of 19.52% compared to FTI Consulting's net margin of 7.57%. Exponent's return on equity of 27.27% beat FTI Consulting's return on equity.Company Net Margins Return on Equity Return on Assets Exponent19.52% 27.27% 15.24% FTI Consulting 7.57%13.15%8.31% Do insiders and institutionals believe in EXPO or FCN? 92.4% of Exponent shares are owned by institutional investors. Comparatively, 99.4% of FTI Consulting shares are owned by institutional investors. 2.1% of Exponent shares are owned by company insiders. Comparatively, 2.5% of FTI Consulting shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has more risk and volatility, EXPO or FCN? Exponent has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500. Comparatively, FTI Consulting has a beta of 0.21, suggesting that its stock price is 79% less volatile than the S&P 500. Does the MarketBeat Community favor EXPO or FCN? Exponent received 71 more outperform votes than FTI Consulting when rated by MarketBeat users. Likewise, 63.17% of users gave Exponent an outperform vote while only 54.38% of users gave FTI Consulting an outperform vote. CompanyUnderperformOutperformExponentOutperform Votes30763.17% Underperform Votes17936.83% FTI ConsultingOutperform Votes23654.38% Underperform Votes19845.62% SummaryExponent beats FTI Consulting on 11 of the 17 factors compared between the two stocks. Remove Ads Get Exponent News Delivered to You Automatically Sign up to receive the latest news and ratings for EXPO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EXPO vs. The Competition Export to ExcelMetricExponentManagement consulting services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$4.06B$2.07B$7.02B$7.57BDividend Yield1.52%2.96%2.70%4.32%P/E Ratio37.699.9929.7317.82Price / Sales7.2717.65154.9794.61Price / Cash39.6062.1331.6134.64Price / Book9.646.104.564.00Net Income$109M$106.41M$195.82M$247.23M7 Day Performance0.14%2.86%-0.27%1.44%1 Month Performance-3.42%-4.30%-6.20%-6.26%1 Year Performance2.24%32.51%4.18%0.59% Exponent Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EXPOExponent4.261 of 5 stars$79.90-1.3%$120.00+50.2%+1.8%$4.06B$558.51M37.691,310Positive NewsFCNFTI Consulting3.8418 of 5 stars$154.89-1.9%$175.50+13.3%-19.5%$5.56B$3.70B19.867,640Positive NewsDNBDun & Bradstreet3.0658 of 5 stars$8.62-1.3%$11.86+37.6%-6.7%$3.85B$2.38B-143.586,360High Trading VolumeCBZCBIZ2.9393 of 5 stars$70.93-1.8%$86.00+21.3%+6.7%$3.81B$1.81B30.056,500Positive NewsHURNHuron Consulting Group4.2139 of 5 stars$136.68-0.8%$169.25+23.8%+56.2%$2.45B$1.52B29.715,660Short Interest ↑Positive NewsHigh Trading VolumeVSECVSE1.9969 of 5 stars$108.13+2.1%$118.67+9.7%+44.7%$2.23B$1.08B130.282,500Positive NewsGap DownICFIICF International4.0862 of 5 stars$81.79-2.7%$140.20+71.4%-42.3%$1.51B$2.02B14.379,000Analyst ForecastShort Interest ↓News CoverageCRAICRA International3.7648 of 5 stars$161.73-2.4%$224.00+38.5%+16.3%$1.10B$687.41M24.00940Positive NewsGap DownACTGAcacia Research2.0772 of 5 stars$3.00+1.7%N/A-39.2%$288.26M$122.31M5.66290Positive NewsHigh Trading VolumeMGMistras Group3.742 of 5 stars$9.02-3.3%N/A+2.2%$279.75M$729.64M25.765,400Short Interest ↑High Trading VolumeFCFranklin Covey3.4578 of 5 stars$20.04-3.0%$42.50+112.1%-46.8%$264.38M$287.92M13.631,150Short Interest ↑High Trading Volume Remove Ads Related Companies and Tools Related Companies FTI Consulting Alternatives Dun & Bradstreet Alternatives CBIZ Alternatives Huron Consulting Group Alternatives VSE Alternatives ICF International Alternatives CRA International Alternatives Acacia Research Alternatives Mistras Group Alternatives Franklin Covey Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EXPO) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exponent, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exponent With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.